TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media
Click for best price
MARKET INSIGHTS
Global Solid Medicines Preparation Equipment market was valued at USD 16.58 billion in 2025. The market is projected to grow from USD 18.44 billion in 2026 to USD 34.17 billion by 2034, exhibiting a CAGR of 11.2% during the forecast period.
Solid preparation equipment refers to a series of mechanical equipment used for the production of solid preparation drugs, covering various processes such as pretreatment, granulation, mixing, molding, cleaning, and packaging. These can be divided into process equipment and non-process equipment.
The market is experiencing robust growth driven by surging demand for solid dosage forms like tablets and capsules, which represent over 70% of global pharmaceutical products, alongside expanding biopharma manufacturing and stricter GMP regulations. Furthermore, automation and digital integration in production lines are accelerating adoption. Key players such as Bosch Packaging Technology, IMA Group, GEA, Syntegon, Telstar (Azbil), Camfil, Morimatsu, Zhejiang Canaan Technology Limited, Tofflon Science and Technology Group Co., Ltd., and Truking Technology Limited dominate with innovative portfolios, fueling further expansion through R&D and strategic collaborations.
Rising Demand for Solid Dosage Forms to Propel Equipment Adoption
Solid dosage forms such as tablets and capsules continue to dominate the global pharmaceutical market due to their stability, ease of administration, and cost-effectiveness in large-scale production. This sustained preference drives substantial investments in advanced solid medicines preparation equipment, encompassing processes from granulation and mixing to compression and coating. As global pharmaceutical output expands to meet the needs of an aging population and rising chronic disease prevalence, manufacturers increasingly rely on high-efficiency equipment to maintain consistent quality and throughput. Recent technological integrations, including automation and real-time process monitoring, further enhance production capabilities while ensuring compliance with stringent Good Manufacturing Practices (GMP).
Expansion of Generic Drug Manufacturing to Fuel Market Growth
The global surge in generic drug production represents a major catalyst for the solid medicines preparation equipment market. Patent expirations for blockbuster drugs have accelerated the need for efficient, scalable manufacturing solutions capable of handling high-volume output with precision. Equipment providers are responding with innovations in tablet presses, capsule fillers, and continuous manufacturing systems that reduce downtime and material waste. This shift not only supports affordability in healthcare but also stimulates demand across emerging markets where access to essential medicines remains a priority. Furthermore, contract development and manufacturing organizations (CDMOs) are expanding their solid dosage capabilities, creating additional opportunities for equipment upgrades and new installations.
Moreover, growing regulatory emphasis on quality assurance and process validation encourages the adoption of modern preparation equipment featuring advanced controls and data integrity features. The global Solid Medicines Preparation Equipment market was valued at 16580 million in 2025 and is projected to reach US$ 34170 million by 2034, at a CAGR of 11.2% during the forecast period.
➤ Process equipment innovations, including high-shear granulators and fluid bed dryers, play a pivotal role in improving product uniformity and bioavailability of solid formulations.
Furthermore, the increasing trend of mergers and acquisitions among major players, along with geographical expansion into high-growth regions, is anticipated to drive the growth of the market over the forecast period.
MARKET CHALLENGES
High Capital Investment Requirements Tend to Challenge Market Growth
The market is experiencing robust expansion; however, it faces notable barriers related to the substantial upfront costs associated with acquiring and implementing state-of-the-art solid medicines preparation equipment. Advanced systems incorporating automation, containment technologies for potent compounds, and continuous manufacturing lines demand significant financial commitments, which can strain budgets especially for smaller pharmaceutical firms and facilities in developing regions. These investments extend beyond initial purchase to include installation, validation, and ongoing maintenance, creating hurdles in price-sensitive markets.
Other Challenges
Regulatory Hurdles
Stringent compliance requirements from authorities worldwide add layers of complexity to equipment deployment and operation. Meeting evolving standards for process validation, cleaning verification, and data integrity requires extensive documentation and testing, which can delay project timelines and increase overall costs. Navigating these frameworks often proves time-consuming and resource-intensive for manufacturers.
Supply Chain Complexities
Disruptions in the availability of critical components and raw materials for equipment fabrication can impede timely delivery and servicing. Global events affecting logistics and sourcing have highlighted vulnerabilities in the supply ecosystem, potentially affecting production schedules for pharmaceutical companies reliant on new or upgraded machinery.
Technical Integration Challenges and Skilled Labor Shortage to Deter Market Growth
While solid medicines preparation equipment offers significant advantages for pharmaceutical production, integration into existing facilities presents technical complexities. Retrofitting older plants with modern automated lines or continuous processing systems often requires substantial facility modifications and compatibility assessments. Issues such as powder handling characteristics, cross-contamination risks, and precise control of critical process parameters demand specialized expertise that may not be readily available.
Additionally, the rapid evolution of manufacturing technologies requires a workforce proficient in areas ranging from equipment operation to data analytics and predictive maintenance. The pharmaceutical sector faces a growing shortage of such skilled professionals, further complicated by competitive labor markets and the need for continuous training. These factors collectively slow the pace of technology adoption across various market segments, from process equipment like granulators and tablet presses to non-process supporting systems.
Surge in Strategic Initiatives and Technological Advancements to Provide Profitable Opportunities for Future Growth
Rising investments in pharmaceutical manufacturing infrastructure, particularly in Asia and other emerging regions, are expected to create lucrative opportunities for solid medicines preparation equipment providers. Demand for flexible, modular systems that support both small-batch personalized medicines and high-volume generics continues to grow. Key market players are actively pursuing partnerships, technology licensing, and capacity expansions to address these diverse needs while enhancing overall equipment efficiency and sustainability.
Additionally, the shift toward continuous manufacturing and Industry 4.0 integration presents substantial prospects. These approaches promise reduced cycle times, improved quality control through real-time monitoring, and lower operational costs compared to traditional batch processing. Equipment manufacturers focusing on smart sensors, AI-driven optimization, and enhanced containment solutions are well-positioned to capture greater market share as pharmaceutical companies modernize their operations.
Solid preparation equipment refers to a series of mechanical equipment used for the production of solid preparation drugs, covering various processes such as pretreatment, granulation, mixing, molding, cleaning and packaging, which can be divided into process equipment and non-process equipment. Strategic initiatives by leading companies, including those serving biological and pharmaceutical enterprises as well as scientific research institutions, are expected to further accelerate innovation and market penetration globally.
Process Equipment Segment Dominates the Market Due to its Critical Role in Drug Manufacturing
The market is segmented based on type into:
Process Equipment
Subtypes: Granulation, Mixing, Blending, Drying, Milling, Tablet Pressing, Coating, and others
Non-process Equipment
Subtypes: Cleaning, Sterilization, Packaging, Material Handling, Inspection, and others
Biological and Pharmaceutical Enterprises Segment Leads Due to High Demand for Solid Dosage Forms
The market is segmented based on application into:
Biological and Pharmaceutical Enterprises
Scientific Research Institutions
Contract Manufacturing Organizations (CMOs)
Hospitals and Healthcare Facilities
Others
Large Pharmaceutical Manufacturers Segment Leads Due to High Volume Production Requirements
The market is segmented based on end user into:
Large Pharmaceutical Manufacturers
Generic Drug Manufacturers
Contract Manufacturing Organizations
Academic and Research Laboratories
Others
Companies Strive to Strengthen their Product Portfolio to Sustain Competition
The competitive landscape of the market is semi-consolidated, with large, medium, and small-size players operating in the market. Bosch Packaging Technology is a leading player in the market, primarily due to its advanced product portfolio and strong global presence across North America, Europe, and Asia.
IMA Group and GEA also held a significant share of the market in 2024. The growth of these companies is attributed to their innovative portfolio and strong presence in pharmaceutical manufacturing end-markets.
Additionally, these companies' growth initiatives, geographical expansions, and new product launches are expected to grow the market share significantly over the projected period.
Meanwhile, Syntegon and Telstar(Azbil) are strengthening their market presence through significant investments in R&D, strategic partnerships, and innovative product expansions, ensuring continued growth in the competitive landscape.
Bosch Packaging Technology
IMA Group
GEA
Syntegon
Camfil
Morimatsu
Zhejiang Canaan Technology Limited
Tofflon Science And Technology Group Co.,ltd.
Trukung Technology Limited
Zhejiang Yaguang Technology Co.,Ltd.
Chanse Technology (Jiangsu) Inc.
Nano Pharm Tech Machinery Equipment
Zhejiang Xiaolun Pharmaceutical Machinery
The solid medicines preparation equipment market is experiencing a transformative shift as manufacturers embrace automation, robotics, and smart manufacturing principles to enhance productivity and product quality. Advanced processing lines now integrate programmable logic controllers, real‑time monitoring sensors, and artificial intelligence‑based analytics that enable predictive maintenance, minimize downtime, and ensure consistent granule size distribution. According to recent industry assessments, facilities that have deployed fully automated granulation and blending systems report up to a 30 % reduction in batch cycle time and a 20 % decrease in raw material waste compared with semi‑automatic setups. The adoption of continuous manufacturing platforms, supported by modular equipment designs, further allows seamless scale‑up from pilot to commercial production while maintaining stringent regulatory compliance. These technological upgrades are not only driven by the need for operational efficiency but also by evolving regulatory expectations that emphasize quality by design and process validation. Consequently, capital expenditure on automation‑focused solid preparation equipment is projected to rise steadily, contributing significantly to the overall market expansion. The global solid medicines preparation equipment market was valued at approximately USD 16,580 million in 2025 and is forecast to reach USD 34,170 million by 2034, reflecting a compound annual growth rate (CAGR) of 11.2 % over the period. In the United States, the market size is estimated at around USD 5,200 million in 2025, while China is anticipated to surpass USD 9,000 million by 2034, underscoring the rapid uptake of advanced equipment in both established and emerging pharmaceutical hubs. The process equipment segment, which includes mixers, granulators, dryers, and tablet presses, is expected to account for the bulk of this growth, reaching an estimated USD 22,500 million by 2034 with a CAGR of roughly 12 % within the next six years. Moreover, the top five global players Bosch Packaging Technology, IMA Group, GEA, Syntegon, and Telstar (Azbil) together held close to 45 % of the total market revenue in 2025, indicating a consolidated yet competitive landscape where innovation in automation serves as a key differentiator.
Personalized Medicine and Small Batch Production
The rise of personalized therapeutics, including patient‑specific oncology drugs, gene‑therapy vectors, and niche hormonal formulations, is reshaping demand for solid medicines preparation equipment toward greater flexibility and smaller batch capabilities. Traditional large‑scale batch lines are being supplemented or replaced by modular, skid‑mounted units that can be quickly re‑configured for different formulations, strengths, and release profiles. This adaptability is essential for contract manufacturing organizations (CMOs) and specialty pharma firms that handle multiple low‑volume projects simultaneously. Industry data suggests that the segment of equipment designed for batches under 100 kilograms is expanding at a CAGR of approximately 13 % through 2034, driven by the proliferation of orphan drugs and cell‑based therapies requiring precise dosing and minimal hold‑up volumes. Furthermore, single‑use technologies such as disposable mixing bowls, filter housings, and containment systems are gaining traction due to their ability to reduce cross‑contamination risks and shorten changeover times between products. These solutions also align with sustainability goals by lowering water and cleaning agent consumption. Regulatory agencies have begun to issue guidance that supports the use of flexible manufacturing approaches, provided that robust process validation and quality control measures are in place. As a result, equipment manufacturers are investing in design platforms that offer scalable throughput, interchangeable tooling, and integrated real‑time analytics to monitor critical quality attributes throughout the production cycle. The convergence of personalized medicine demands and advanced equipment flexibility is expected to create new revenue streams, particularly in regions with strong biotech clusters such as Massachusetts, California, and the Rhine‑Main area in Germany.
Emerging economies are becoming pivotal contributors to the global solid medicines preparation equipment market, propelled by rising domestic healthcare spending, government incentives for local drug production, and the strategic relocation of manufacturing activities by multinational corporations. China’s pharmaceutical sector, supported by its “Made in China 2025” initiative, has witnessed a surge in greenfield investments for solid dosage form facilities, especially in the Tier‑1 and Tier‑2 cities of Guangdong, Jiangsu, and Zhejiang. Consequently, China’s market for solid preparation equipment is projected to exceed USD 9,000 million by 2034, expanding at a CAGR of roughly 11 % from its 2025 baseline. India is similarly experiencing robust growth, with the government’s Production‑Linked Incentive (PLI) scheme attracting both domestic and foreign players to establish high‑capacity tablet and capsule lines. The Indian market is anticipated to approach USD 4,300 million by 2034, reflecting a CAGR of about 10.5 %. Southeast Asian nations such as Vietnam, Thailand, and Malaysia are also benefiting from favorable trade agreements and lower operational costs, prompting equipment suppliers to set up regional service centers and localized assembly operations. In Latin America, Brazil and Mexico are gradually modernizing their existing plants to meet stricter good manufacturing practice (GMP) standards, creating replacement demand for newer granulation, drying, and packaging equipment. Overall, the shift toward regional manufacturing is expected to reduce reliance on traditional export hubs and diversify the geographic revenue base for equipment vendors. This trend is reinforced by the increasing presence of global contract manufacturing organizations that are establishing footholds in these markets to offer end‑to‑end solutions from formulation development to commercial supply. As a result, the aggregate share of the Asia‑Pacific, Latin America, and Middle East‑Africa regions in the global solid medicines preparation equipment market is forecast to rise from approximately 38 % in 2025 to nearly 45 % by 2034, underscoring the strategic importance of emerging economies in shaping the industry’s future trajectory.
North America
The North American market for solid medicines preparation equipment is characterized by a mature pharmaceutical sector, stringent regulatory oversight, and a strong emphasis on technological advancement. Facilities in the United States and Canada must comply with current Good Manufacturing Practices (cGMP) enforced by the FDA, which drives demand for equipment that offers precise control over granule size, moisture content, and tablet hardness. The region benefits from a high concentration of large‑scale biologics and small‑molecule manufacturers that invest heavily in continuous processing and automation to improve yield and reduce batch‑to‑batch variability. Recent trends show a shift toward modular granulation lines that can be reconfigured for multiple product families, thereby increasing equipment utilization and lowering capital expenditure risk. Additionally, the push for environmentally sustainable manufacturing has led to increased interest in dry granulation technologies that eliminate the need for solvent‑based binders, reducing volatile organic compound (VOC) emissions. Mexico’s growing role as a manufacturing hub for generic drugs further contributes to regional demand, particularly for cost‑effective, semi‑automated equipment that can serve both domestic and export markets. Overall, North America’s market growth is underpinned by continuous innovation, regulatory compliance requirements, and the strategic advantage of having a well‑established supply chain for high‑purity excipients and active pharmaceutical ingredients.
Europe
Europe’s solid medicines preparation equipment market is shaped by the region’s stringent regulatory framework under the European Medicines Agency (EMA) and the EU’s REACH legislation, which encourage the adoption of cleaner, more efficient processing technologies. Countries such as Germany, France, and the United Kingdom host a significant number of multinational pharmaceutical corporations that prioritize equipment delivering high precision, scalability, and data integrity for modern quality‑by‑design (QbD) approaches. There is a noticeable increase in the deployment of continuous wet granulation and hot melt extrusion systems, especially for products requiring enhanced bioavailability or modified‑release profiles. The push for sustainability has also accelerated interest in solvent‑free granulation techniques and energy‑efficient drying technologies, which align with EU climate objectives. In Eastern Europe, expanding contract manufacturing organizations (CMOs) are investing in versatile, mid‑range equipment that can accommodate a broad portfolio of generic and over‑the‑counter (OTC) products. The region benefits from strong academic‑industry collaborations that foster innovation in powder handling and process analytics, further supporting equipment upgrades. Despite economic variability in certain markets, the overall outlook remains positive due to the region’s commitment to maintaining high manufacturing standards while adapting to evolving therapeutic demands, particularly in areas such as oncology and central nervous system therapeutics.
Asia‑Pacific
The Asia‑Pacific region represents the fastest‑growing market for solid medicines preparation equipment, driven by expanding pharmaceutical production capacities in China, India, Japan, and South Korea. China’s ambitious “Made in China 2025” initiative and substantial government support for domestic drug manufacturing have resulted in large‑scale investments in modern granulation, blending, and tablet‑pressing lines. India’s role as a leading supplier of generic medicines fuels demand for high‑throughput, cost‑competitive equipment that can meet stringent international regulatory standards for export to regulated markets. Japan and South Korea, with their focus on innovative drug delivery systems, are adopting advanced technologies such as continuous milling and spray drying to support the development of complex formulations, including inhalable powders and nanocrystal‑based products. Southeast Asian nations, including Vietnam and Thailand, are experiencing rising investments in contract manufacturing, prompting a need for flexible equipment that can handle multiple product lines with minimal changeover time. Across the region, there is a growing awareness of the benefits of process analytical technology (PAT) and real‑time release testing, which encourages the integration of sensors and data‑management platforms into preparation lines. While cost sensitivity remains a factor, particularly for smaller manufacturers, the overall trend points toward gradual automation and technology adoption to improve productivity, ensure product quality, and comply with increasingly harmonized global regulations.
South America
In South America, the market for solid medicines preparation equipment is emerging, driven by increasing domestic demand for pharmaceuticals and governmental efforts to strengthen local manufacturing capabilities. Brazil, as the region’s largest economy, has implemented policies to reduce reliance on imported finished drugs, encouraging investment in modern tablet‑compression, granulation, and mixing equipment. Argentina and Chile are also witnessing modest growth in their pharmaceutical sectors, particularly in the production of over‑the‑counter (OTC) medications and basic antibiotics, which creates a need for reliable, semi‑automated processing lines. However, the region faces challenges such as economic volatility, currency fluctuations, and uneven regulatory enforcement, which can affect the timing and scale of capital expenditures. Many manufacturers opt for refurbished or lower‑cost equipment to mitigate financial risk, although there is a growing interest in technologies that offer better energy efficiency and lower operating costs, especially in response to rising energy prices. Local distributors of European and Asian equipment suppliers are expanding their service networks to provide after‑sales support, spare parts, and technical training, which helps build confidence in more sophisticated systems. Despite these hurdles, the long‑term outlook is positive, as rising healthcare access, an expanding middle class, and continued government incentives for local production are expected to stimulate sustained demand for solid medicines preparation equipment across the continent.
Middle East & Africa
The solid medicines preparation equipment market in the Middle East and Africa (MEA) is at a nascent stage but shows promising signs of growth propelled by healthcare infrastructure development and increasing pharmaceutical localization efforts. Countries such as the United Arab Emirates, Saudi Arabia, and Qatar have launched national vision programs aimed at reducing dependence on imported medicines by fostering domestic production capabilities. This has led to investments in modern granulation, blending, and tablet‑pressing facilities, often equipped with advanced automation and compliance features to meet international standards. In Africa, South Africa leads the region with a relatively established pharmaceutical manufacturing base that serves both domestic demand and export to other African nations; here, there is a steady demand for equipment that can handle a diverse portfolio of products, including antiretrovirals and vaccines. Other African markets, including Kenya, Nigeria, and Egypt, are experiencing gradual growth in local production, supported by donor‑funded initiatives and public‑private partnerships aimed at strengthening health security. Nonetheless, the region confronts obstacles such as limited access to financing, inconsistent power supply, and varying degrees of regulatory harmonization, which can impede the adoption of high‑capital equipment. Suppliers are responding by offering scalable, modular solutions that can be implemented in phases and by providing robust training and maintenance services to ensure operational continuity. Over the medium to long term, continued government focus on healthcare self‑sufficiency, rising disease burden, and efforts to attract foreign direct investment are expected to drive incremental but meaningful expansion of the solid medicines preparation equipment market across the MEA region.
This market research report offers a holistic overview of global and regional markets for the forecast period 2025–2032. It presents accurate and actionable insights based on a blend of primary and secondary research.
✅ Market Overview
Global and regional market size (historical & forecast)
Growth trends and value/volume projections
✅ Segmentation Analysis
By product type or category
By application or usage area
By end-user industry
By distribution channel (if applicable)
✅ Regional Insights
North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
Country-level data for key markets
✅ Competitive Landscape
Company profiles and market share analysis
Key strategies: M&A, partnerships, expansions
Product portfolio and pricing strategies
✅ Technology & Innovation
Emerging technologies and R&D trends
Automation, digitalization, sustainability initiatives
Impact of AI, IoT, or other disruptors (where applicable)
✅ Market Dynamics
Key drivers supporting market growth
Restraints and potential risk factors
Supply chain trends and challenges
✅ Opportunities & Recommendations
High-growth segments
Investment hotspots
Strategic suggestions for stakeholders
✅ Stakeholder Insights
Target audience includes manufacturers, suppliers, distributors, investors, regulators, and policymakers
-> Key players include Bosch Packaging Technology, IMA Group, GEA, Syntegon, Telstar (Azbil), Camfil, Morimatsu, Zhejiang Canaan Technology Limited, Tofflon Science And Technology Group Co.,ltd., Truking Technology Limited, among others.
-> Key growth drivers include rising demand for solid dosage forms, expansion of generic drug manufacturing, increasing adoption of automation and continuous manufacturing technologies, and stringent regulatory requirements for product quality.
-> Asia-Pacific is the fastest‑growing region, while North America and Europe hold substantial market shares due to established pharmaceutical infrastructure and ongoing investments in advanced manufacturing.
-> Emerging trends include continuous manufacturing, single‑use equipment, AI‑enabled process analytics, sustainability initiatives such as green solvent use and energy‑efficient designs, and modular, flexible production lines.
| Report Attributes | Report Details |
|---|---|
| Report Title | Solid Medicines Preparation Equipment Market - AI Innovation, Industry Adoption and Global Forecast 2026-2034 |
| Historical Year | 2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year | 2025 |
| Forecast Year | 2033 |
| Number of Pages | 117 Pages |
| Customization Available | Yes, the report can be customized as per your need. |
Frequently Asked Questions
